P04.19 METABOLIC IMPACT OF ANTI-ANGIOGENIC AGENTS ON GLIOMA CELLS

Por Mesti, T., Savarin, P., Triba, M.N., Ocvirk, J., Banissi, C., Carpentier, A.F.
Publicado em 2014

Protein kinase Cγ autoimmunity in paraneoplastic cerebellar degeneration and non‐small‐cell lung cancer

Por Sabater, L, Bataller, L, Carpentier, A F, Aguirre‐Cruz, M L, Saiz, A, Benyahia, B, Dalmau, J, Graus, F
Publicado em 2006

Hu‐antibody‐positive patients with or without cancer have similar clinical profiles

Por Lladó, A, Carpentier, A F, Honnorat, J, Sillevis‐Smitt, P, Twijnstra, A, Blanco, Y, Hart, I K, Saiz, A, Graus, F
Publicado em 2006

P15.16 EVOLUTION OF THE FUNCTIONAL INDEPENDENCE IN GLIOBLASTOMA PATIENTS

Por Sacko, A., Hou, M., Temgoua, M., Ursu-Billot, R., Marantidou, A., Doridam, J., Coman, I., Belin, C., Levy-Piedbois, C., Carpentier, A.F.
Publicado em 2014